Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
17 | 3 | IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL | 124793 |
201 | 2 | IMMUNOTHERAPY//DENDRITIC CELLS//MYELOID DERIVED SUPPRESSOR CELLS | 20719 |
24410 | 1 | CANC VACCINE DEV//INNOVAT CANC THER Y//PERSONALIZED PEPTIDE VACCINE | 336 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | CANC VACCINE DEV | address | 2252366 | 13% | 56% | 43 |
2 | INNOVAT CANC THER Y | address | 1963105 | 27% | 23% | 90 |
3 | PERSONALIZED PEPTIDE VACCINE | authKW | 873053 | 3% | 85% | 11 |
4 | PEPTIDE VACCINE | authKW | 635187 | 13% | 15% | 45 |
5 | CANC VACCINE | address | 546558 | 12% | 15% | 39 |
6 | ONCOANTIGEN | authKW | 482395 | 2% | 86% | 6 |
7 | DEPDC1 | authKW | 422094 | 2% | 75% | 6 |
8 | SART3 | authKW | 422094 | 2% | 75% | 6 |
9 | KIF20A | authKW | 375194 | 2% | 67% | 6 |
10 | IMMUNOL IMMUNOTHER Y | address | 341992 | 8% | 13% | 28 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 5637 | 66% | 0% | 223 |
2 | Immunology | 554 | 21% | 0% | 69 |
3 | Medicine, Research & Experimental | 136 | 9% | 0% | 29 |
4 | Urology & Nephrology | 86 | 5% | 0% | 18 |
5 | Cell & Tissue Engineering | 46 | 1% | 0% | 4 |
6 | Cell Biology | 11 | 5% | 0% | 17 |
7 | Endocrinology & Metabolism | 9 | 3% | 0% | 11 |
8 | Gastroenterology & Hepatology | 6 | 2% | 0% | 7 |
9 | Hematology | 6 | 2% | 0% | 7 |
10 | Transplantation | 2 | 1% | 0% | 3 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CANC VACCINE DEV | 2252366 | 13% | 56% | 43 |
2 | INNOVAT CANC THER Y | 1963105 | 27% | 23% | 90 |
3 | CANC VACCINE | 546558 | 12% | 15% | 39 |
4 | IMMUNOL IMMUNOTHER Y | 341992 | 8% | 13% | 28 |
5 | GENET CLIN ONCOL | 187599 | 1% | 100% | 2 |
6 | KURUME UNIV INNOVAT CANC THER Y | 168837 | 1% | 60% | 3 |
7 | 21ST CENTURY COE PROGRAM MED SCI | 143619 | 2% | 22% | 7 |
8 | CANC VACCINES | 140696 | 1% | 50% | 3 |
9 | BIOFUNCT MICRIBIOTA | 125065 | 1% | 67% | 2 |
10 | SURG BIOENGNMINATO KU | 105521 | 1% | 38% | 3 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CANCER SCIENCE | 38347 | 12% | 1% | 39 |
2 | ONCOIMMUNOLOGY | 5124 | 2% | 1% | 8 |
3 | INTERNATIONAL JOURNAL OF ONCOLOGY | 5068 | 7% | 0% | 23 |
4 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 4740 | 4% | 0% | 15 |
5 | JOURNAL OF IMMUNOTHERAPY | 3505 | 2% | 0% | 8 |
6 | CLINICAL CANCER RESEARCH | 2950 | 7% | 0% | 22 |
7 | PROSTATE | 2434 | 3% | 0% | 11 |
8 | CANCER IMMUNOLOGY RESEARCH | 1653 | 1% | 1% | 3 |
9 | JOURNAL OF TRANSLATIONAL MEDICINE | 1365 | 2% | 0% | 6 |
10 | ESOPHAGUS | 1161 | 1% | 1% | 2 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PERSONALIZED PEPTIDE VACCINE | 873053 | 3% | 85% | 11 | Search PERSONALIZED+PEPTIDE+VACCINE | Search PERSONALIZED+PEPTIDE+VACCINE |
2 | PEPTIDE VACCINE | 635187 | 13% | 15% | 45 | Search PEPTIDE+VACCINE | Search PEPTIDE+VACCINE |
3 | ONCOANTIGEN | 482395 | 2% | 86% | 6 | Search ONCOANTIGEN | Search ONCOANTIGEN |
4 | DEPDC1 | 422094 | 2% | 75% | 6 | Search DEPDC1 | Search DEPDC1 |
5 | SART3 | 422094 | 2% | 75% | 6 | Search SART3 | Search SART3 |
6 | KIF20A | 375194 | 2% | 67% | 6 | Search KIF20A | Search KIF20A |
7 | TIP110 | 300157 | 1% | 80% | 4 | Search TIP110 | Search TIP110 |
8 | CANCER PEPTIDE VACCINE | 281398 | 1% | 100% | 3 | Search CANCER+PEPTIDE+VACCINE | Search CANCER+PEPTIDE+VACCINE |
9 | PEPTIDE COCKTAIL | 281398 | 1% | 100% | 3 | Search PEPTIDE+COCKTAIL | Search PEPTIDE+COCKTAIL |
10 | URLC10 | 281398 | 1% | 100% | 3 | Search URLC10 | Search URLC10 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |
rank | cluster_id2 | link |
---|---|---|
1 | 1356 | CANCER TESTIS ANTIGEN//NY ESO 1//MAGE |
2 | 11302 | TUMOR IMMUNOL BIOL//SIPULEUCEL T//PROSTVAC |
3 | 31085 | GV1001//UNITE VIROL MOL VECTOROL//VAXON BIOTECH |
4 | 27441 | RAS DERIVED PEPTIDES//P53 PEPTIDES//RAS PEPTIDES |
5 | 16938 | CANC VACCINE DEV PROGRAM//TUMOR VACCINE GRP//CANC IMMUNOL IMMUNOTHER Y |
6 | 24923 | IMP3//CRD BP//KOC |
7 | 35247 | 5T4//5T4 ONCOFETAL ANTIGEN//MEDAWAR |
8 | 26296 | ENDOSIALIN//CD248//TEM1 |
9 | 35753 | IEX 1//IER2//PIP92 |
10 | 19238 | IMMUNOGENIC CELL DEATH//U1015//U805 |